These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 9662590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF, Oei HY, Hennemann G, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S, Menda Y, Adalet I, Boztepe H, Ozbey N, Alagöl F, Cantez S.
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl].
    Nagamachi S, Jinnouchi S, Nishii R, Flores LG, Nakahara H, Futami S, Tamura S, Toshimori H, Kawai K.
    Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567
    [Abstract] [Full Text] [Related]

  • 16. [Thyroglobulin as a tumor marker and thallium scintigraphy for the course control of differentiated thyroid cancer].
    Müller-Brand J, Fridrich R, Spicher E, Staub JJ.
    Schweiz Med Wochenschr; 1983 Mar 05; 113(9):325-7. PubMed ID: 6844904
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM, Kim ES, Ryu JS, Hong SJ, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2003 Apr 05; 58(4):421-7. PubMed ID: 12641624
    [Abstract] [Full Text] [Related]

  • 20. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May 05; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.